About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Videos
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
ALK Resistance in NSCLC
By
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
FEATURING
Angel Qin
By
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
FEATURING
Angel Qin
0 views
May 4, 2023
Comments
0
Login to view comments.
Click here to Login
Featured Video
09:36
Johnson & Johnson
Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…
Feat.
J. Heymach,
M. Das
Featured Video
06:27
Johnson & Johnson
Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC
Feat.
M. Socinski,
D. Waterhouse
Videos
11:37
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
ADCs in SCLC
Feat.
A. Chiang
14:31
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Placing ADCs in the Lung Cancer Treatment Algorithm
Feat.
J. Reuss
11:58
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
ALK Resistance in NSCLC
Feat.
A. Qin
06:09
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
MET Exon 14 Skipping Mutation in NSCLC: An Analysis by Specific Muta…
Feat.
J. Marks
06:36
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Appropriateness of Biomarker Selection for Durvalumab Consolidation …
Feat.
D. Gandara
10:20
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Rare EGFR Mutations in NSCLC: Do We Know Enough to Treat Them Differ…
Feat.
X. Le
19:53
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Consolidation Strategies in SCLC: IO and Radiation
Feat.
N. Abdel Karim
14:23
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Updates on the Use of Consolidation IO in NSCLC Based on Biomarker S…
Feat.
E. Vokes
13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …
Feat.
E. Rodriguez
10:14
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Targeted Therapy in Consolidation Setting for Locally Advanced NSCLC
Feat.
J. West
19:59
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Therapies for Early Stage NSCLC: Adjuvant Chemo/IO
Feat.
J. Spicer
18:53
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Tissue Based Predictors of Immunotherapy
Feat.
N. Vokes
